ICE-HBV Symposium
September 30, 2021
ICE-HBV is organizing a pre-conference interactive workshop on HBV biomarkers aimed at scientists, clinicians, pharmaceutical and diagnostic industry representatives. The workshop, chaired by Anna Kramvis and Peter Revill, is put together by the ICE-HBV serum biomarkers working group. Both classic and future biomarkers will be discussed. The workshop will lead to a consensus statement on promising serum biomarkers.
The workshop will focus on HBV biomarkers, which are necessary for:
- Following the natural history: clinical phases of infection
- Surveillance: identify infected individuals
- Linkage to care and treatment
- Monitoring treatment and response to vaccination
- Prediction of treatment outcomes and the development of hepatocellular carcinoma
- Determining the efficacy of new agents in clinical trials
- HBV cure endpoints
- Detection of occult HBV infection (OBI)
- This will include:
Classical markers: HBsAg, HBeAg, anti-HBs, anti-HBe, anti-HBc, HBV DNA, immunological markers
Novel markers: qHBVDNA, qHBsAg, HBcrAg, HBV RNA
Future markers: qAnti-HBc, Immune complex, qHBeAg, HBsAg isoforms, Integrated DNA, Splice variants, Genotyping assays.
Come back soon for a detailed version of the ICE-HBV Symposium
The ICE-HBV Biomarkers Workshop is organized by:
